IL6 and COVID-19: In agreement with this study, these findings indicated the importance of IL6, TNF and IL1B hub-high traffic genes, considered potential targets (individually or in combination) for development of effective therapeutic immunomodulation strategies to manage COVID-19 hyperinflammation.